HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection
File(s)jem_20191422.pdf (4.01 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Herpes simplex virus (HSV) is the main cause of viral encephalitis in the Western world, and the type I interferon (IFN) system is important for antiviral control in the brain. Here, we have compared Ifnb induction in mixed murine brain cell cultures by a panel of HSV1 mutants, each devoid of one mechanism to counteract the IFN-stimulating cGAS-STING pathway. We found that a mutant lacking the deubiquitinase (DUB) activity of the VP1-2 protein induced particularly strong expression of Ifnb and IFN-stimulated genes. HSV1 ΔDUB also induced elevated IFN expression in murine and human microglia and exhibited reduced viral replication in the brain. This was associated with increased ubiquitination of STING and elevated phosphorylation of STING, TBK1, and IRF3. VP1-2 associated directly with STING, leading to its deubiquitination. Recruitment of VP1-2 to STING was dependent on K150 of STING, which was ubiquitinated by TRIM32. Thus, the DUB activity of HSV1 VP1-2 is a major viral immune-evasion mechanism in the brain.
Date Issued
2020-07-06
Date Acceptance
2020-03-04
Citation
Journal of Experimental Medicine, 2020, 217 (7)
ISSN
0022-1007
Publisher
Rockefeller University Press
Journal / Book Title
Journal of Experimental Medicine
Volume
217
Issue
7
Copyright Statement
© 2020 Bodda et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
Sponsor
Wellcome Trust
Marie Curie Cancer Care
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/32383759
PII: 151747
Grant Number
093643/Z/10/Z
PU/T/WL/09/75
Subjects
Immunology
11 Medical and Health Sciences
Publication Status
Published
Coverage Spatial
United States
Article Number
ARTN e20191422.
Date Publish Online
2020-05-08